Litcius/Paper detail

Leflunomide: Traditional immunosuppressant with concurrent antiviral effects

Kunyu Zheng, Yiran Chen, Suying Liu, Chengmei He, Yunjiao Yang, Di Wu, Li Wang, Mengtao Li, Xiaofeng Zeng, Fengchun Zhang

2022International Journal of Rheumatic Diseases11 citationsDOI

Abstract

Leflunomide is a classic disease-modifying anti-rheumatic drug that is widely used to treat autoimmune diseases. Studies also show its antiviral effects in in vitro and/or in vivo experiments. Considering glucocorticoids, immunosuppressants and newly emerged antibodies commonly used in autoimmune diseases and autoinflammatory disorders bring risk of infection such as viral infection, leflunomide with combination of anti-viral and immunosuppressive features to maintain the balance between infection and anti-inflammation are attractive. Here we summarize the actions and mechanisms of leflunomide in immunoregulatory and antiviral effects.

Topics & Concepts

LeflunomideMedicineImmunologyDrugIn vivoViral infectionAntiviral drugDiseaseAutoimmune diseaseInflammationAntibodyPharmacologyRheumatoid arthritisVirusInternal medicineBiologyBiotechnologySystemic Lupus Erythematosus ResearchImmune Cell Function and InteractionT-cell and B-cell Immunology